UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
October 7, 2022
Accession Number:
0001213900-22-057177
Submission Type:
POS AM
CIK:
0001728328
Company Name:
InMed Pharmaceuticals Inc.
File Number:
333-265731